Insomnia linked to increased risk of death and rapid loss of kidney function

Insomnia may have detrimental effects on individuals' kidney health and their overall survival, according to a study that will be presented at ASN Kidney Week 2017 October 31­–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.

Chronic insomnia is highly prevalent in the world, and the extent of its effects on the body are not fully known. A team led by Csaba Kovesdy, MD, and Jun Ling Lu, MD (University of Tennessee Health Science Center), looked to see whether chronic insomnia might be linked with increased risks of dying early and developing kidney problems in a group of 957,587 US veterans with normal kidney function.

Over a median follow-up of 6.1 years, 23.1% of patients died, 2.7% displayed rapid kidney function decline, and 0.2% developed kidney failure. Chronic insomnia was associated with a 1.4-times increased risk of dying, a 1.5-times increased risk of rapid loss of kidney function, and a 2.4-times increased risk of developing kidney failure.

"Chronic insomnia is an important and relatively common condition among patients with normal kidney function. Attention to its proper management could have long-ranging positive effects," said Dr. Kovesdy. "This hypothesis will need to be examined in dedicated prospective studies, including clinical trials."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients